80 likes | 94 Views
Bullion Premium is one of our premium services. In this service, we provide 3-5 calls in MCX include mcx commodity tips, MCX Bullions, and Mcx live tips, Mcx tips.<br>http://www.capitalstars.com/bullion-premium-mcx-tips/<br>
E N D
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 20 THAUGUST 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 37350.33 INDIAN EQUITY BENCHMARK - Benchmark indices ended marginally higher but last hour selling pressure erased all the intraday gains with Nifty finished around 11,050 level. NIFTY 11047.80 The Sensex was up 52.16 points at 37,402.49, while Nifty CLOSE PREVIOUS was up 6.10 points at 11,053.90. About 1265 shares have NIKKEI 20418.81 advanced, 1209 shares declined, and 154 shares are unchanged. Yes Bank, Indiabulls Housing, Grasim Industries, 25734.22 Power Grid and GAIL were among major losers on the Nifty, 1939.90 while gainers were Sun Pharma, Tech Mahindra, Bharti SECTORIAL INDICES Infratel, Axis Bank and Wipro. Among sectors, auto, FMCG CLOSE CHANGE (%) and metal witnessed selling pressure, while buying seen in CNX 100 11158.95 the infra, IT and pharma. GLOBAL FACE S&P CNX 500 ! CNX 200 Asian Market - Asian markets finished broadly higher today with shares in Hong Kong leading the region. The Hang Seng BANK NIFTY 28186.10 is up 2.17% while China's Shanghai Composite is up 2.10% and Japan's Nikkei 225 is up 0.71%. TOP GAINERS CLOSE CHANGE (%) ! U.S. Market – North and South American markets finished broadly higher on Friday with shares in Mexico leading the SUNPHARMA 426.00 TECHM 673.90 region. The IPC is up 1.98% while U.S.'s S&P 500 is up 1.44% and Brazil's Bovespa is up 0.76%. AXISBANK 685.20 ! 252.50 European markets – European markets are sharply higher today with shares in Germany leading the region. The DAX is up 1.26% while France's CAC 40 is up 1.07% and London's TOP LOSERS CLOSE CHANGE (%) FTSE 100 is up 1.04%. YESBANK -3.34 -2.56 -1.69 GAIL -1.66 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE STRATEGY SELL ON RISE SCRIPT CLOSE (%) 2.72 SUNPHARM PIVOT POINTS P 11079 S3 10861 S2 10970 S1 R1 11121 R2 11188 RESISTANCE R1-11180 R2-11300 R3 11297 1.24 11012 WIPRO 1.22 SUPPORT S1-11020 S2-10900 1.14 CLOSE (%) -3.34 YESBANK 76.80 SBIN -1.50 UPL -1.28 -1.17 NET BUY (CR.) NET INSTITUTION SELL (CR) FII 7129.04 2143.30 TREND STRATEGY SELL ON RISE NSE TOTALS PIVOT POINTS P 28275 SUPPORT DECLINE S S2 27912 S1 28065 R2 R3 29001 INDICES 27548 28428 28638 RESISTANCE R1-28400 R2-28650 NIFTY BANK NIFTY 5 7 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS Sebi to ease buyback norms for cos! with housing finance, subsidiaries: Capital markets regulator SEBI is planning to norms for buyback of especially those having subsidiaries in housing finance and NBFC sectors. According to top officials, a proposal in this regard is expected to be discussed by SEBI's board at its meeting this week. The repurchase of shares by listed companies is governed by the Buyback Regulations of the Securities and Exchange Board of India (SEBI) as well as by the Companies Act. Dr Reddy's launches biosimilar of Roche's Avastin in India Dr. Reddy's Laboratories Ltd has launched (bevacizumab), a biosimilar of Roche's Avastin in India, indicated for the treatment of several types of cancers (metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, cervical cancer, metastatic breast cancer and epithelial ovarian, fallopian tube and primary peritoneal cancer). Dr. Reddy's Versavo is available in strengths of 100mg and 400mg single-use vials. Avastin and its biosimilars had India sales of approximately Rs223cr MAT for the most recent twelve months ending in December 2018, according to Ipsos. ! DHFL stock hits upper circuit after lenders approve resolution plan Shares of DHFL hit an upper circuit at Rs50.45 on the BSE in the late morning trade. According to the media reports, the lenders to the NBFC gave their go-ahead to a three-level resolution plan presented by the Wadhawan group company. Also, the media report stated that the plan includes conversion of debt to equity and issuance of nonconvertible debentures, steps that will give creditors majority stake in the embattled financier and help resume stalled credit lines. The company stated on Friday that it is not in a position to release quarterly results in time due to the full-time engagement of NBFC ease its by listed companies, ! accounts and finance teams in various non-routine audits and the due diligence by various parties. The company to ensure submitting the quarterly results by September 14. Versavo ! Titan stock gains after increasing stake in arm Carat Lane Shares of Titan Company gained 1% on the BSE after the company has purchased 9.45 lakh equity shares from one of the shareholders of Carat Lane Trading Private Limited (CaratLane), a subsidiary of the Company, thereby increasing its stake in CaratLane by 2.8%. The shareholding of the company in CaratLane has increased from 69.5% to 72.3%, the company said in the filing. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : REPCOHOME DATE : 20/08/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY REPCOHOME IN CASH ABOVE 327 TGT 334 SL 320 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Tips Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.